In English | En español
Questions About Cancer? 1-800-4-CANCER

Neuroblastoma Treatment (PDQ®)

  • Updated: 08/29/2014

Table 2. Histologic Discrimination of International Neuroblastoma Risk Group Subsets of Neuroblastoma Patientsa

INSS Stage/Histologic Subtype Number of Cases EFS (%)  OS (%) 
INSS stage 1, 2, 3, 4S5,13183 ± 191 ± 1
GN, maturing16297 ± 298 ± 2
GNB, intermixed
NB4,97083 ± 190 ± 1
GNB, nodular
INSS stage 2, 3; age >547 d26069 ± 381 ± 2
11q normal and differentiating1680 ± 16100
11q aberration or undifferentiated4961 ± 1173 ± 11

EFS = event-free survival; GN = ganglioneuroma; GNB = ganglioneuroblastoma; INSS = International Neuroblastoma Staging System; NB = neuroblastoma; OS = overall survival.
aAdapted from Cohn et al.[8]

References

  1. Cohn SL, Pearson AD, London WB, et al.: The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27 (2): 289-97, 2009.  [PUBMED Abstract]